Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Industry Organization
Biotechnology organization asserts proposed changes to patent rules would harm biotech companies
June 2nd, 2006
The Biotechnology Industry Organization (BIO) opposes recent changes imposed by the U.S. Patent and Trademark Office (PTO) because it says they would have a negative impact on biotechnology companies. Recently, the U.S. Patent and Trademark Office (PTO) proposed changes to patent rules that would restrict the number of claims examined in a single application and limit inventors' rights to file continuation applications. "BIO believes that the PTO's proposed rule changes will stifle biotech innovation," BIO president and CEO Jim Greenwood stated. "It can take decades to develop a patented biotechnology invention, in part because these inventions must...
Source: Medicine & Law Weekly (2006-06-02)
|
